Heart failure with normal ejection fraction clinical trials
Showing 51–63 of 63 active trials. Describe your situation to see which ones you may be eligible for.
- Boston Medical Center Ultrasound Decongestion Study in Heart Failure
- IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency
- Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
- Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
- Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure
- Chronic Exogenous Ketosis in HFpEF
- The Effect of Adiposity on Muscle and Microvascular Function in HFpEF
- Enhancing the Natriuretic Peptide System in HFpEF
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
- A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)
- Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
- Testing the CHAT Program for Patients With Heart Failure
- The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.